Proov Complete Fertility Testing System vs Easy@Home Ovulation Test Strips - Clinical Comparison

Proov Complete Fertility Testing System

The Proov Complete Fertility Testing System is a multi-hormone diagnostic platform designed to provide a holistic view of the menstrual cycle, moving beyond simple surge prediction to include ovulation confirmation. The system utilizes lateral flow assays to track four critical biomarkers: Follicle-Stimulating Hormone (FSH) to assess follicle recruitment, Estrone-3-Glucuronide (E1G) to identify the opening of the fertile window, Luteinizing Hormone (LH) to detect the peak surge, and Pregnanediol Glucuronide (PdG) to confirm that an egg was successfully released. A primary differentiator of Proov is its focus on the 'Progesterone Score,' which evaluates PdG levels during the critical implantation window. Clinical evaluation, including a study on ClinicalTrials.gov (NCT03924440), supports the system's ability to identify luteal phase deficiencies that standard LH-only tests miss. While the tests are qualitative strips, the Proov Insight app uses AI-driven optical scanning to interpret results and provide quantitative-style insights. This makes the system an invaluable resource for users with PCOS, endometriosis, or those over 35 who want to ensure their cycles are anovulatory and healthy.

Easy@Home Ovulation Test Strips

Easy@Home Ovulation Test Strips have established a dominant position in the at-home reproductive diagnostic market by prioritizing economic accessibility for high-volume users. These lateral flow assays utilize a standard clinical sensitivity threshold of 25 mIU/mL to detect the Luteinizing Hormone (LH) surge that precedes ovulation. While the strips themselves are qualitative, their clinical utility is significantly enhanced when paired with the Premom companion app. The app utilizes sophisticated image processing to calculate a T/C ratio (Test line intensity relative to the Control line), effectively digitizing the results and allowing users to visualize their unique LH progression curve. This approach is particularly valuable for individuals who experience a 'rapid onset' surge, as the low cost per strip-averaging under $0.40 in bulk kits-makes testing multiple times per day sustainable. Clinical performance data validates that these strips are over 99% accurate in detecting LH surges when protocol is strictly followed. While they lack the dual-hormone monitoring of premium digital systems, the combination of high piece counts and algorithmic tracking provides a robust foundation for identifying the 48-hour fertile window.